secwatch.observer — SEC 8-K summary
======================================

Issuer:     FibroBiologics, Inc. (FBLG)
CIK:        0001958777
Form:       8-K
Filed at:   2025-01-24T23:59:59+00:00
Accession:  0001493152-25-003571
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

FibroBiologics board approves 2024 incentive bonuses for CEO O'Heeron and other executives
--------------------------------------------------------------------------------

- CEO Pete O'Heeron received $390,000 non-equity incentive bonus, total compensation $1,805,199 for 2024.
- CSO Hamid Khoja received $150,000 bonus, total compensation $853,646.
- GC Ruben Garcia (hired March 2024) received $142,188 bonus, total compensation $2,752,843 including option grant.
- Interim CFO Robert Hoffman awarded a $75,000 bonus for 2024.
- Bonuses were previously undetermined and approved on January 23, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1958777/000149315225003571/0001493152-25-003571-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1958777/000149315225003571/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-003571

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer